본문 바로가기 주메뉴 바로가기

2018 HIVF Program

HIVF Program
Date Time Contents Speaker
Nov. 15
(Thu)
08:00 ~ 09:00 Registration
09:00 ~ 10:00 Opening Ceremony
10:00 ~ 10:10 Break
10:10 ~ 12:50 Session 1. Frontiers in New Paradigm Vaccines
10:10 ~ 10:50 Principles of Structure-Based Vaccine Design Chief Peter Kwong
10:50 ~ 11:30 Technologies to facilitate a rapid response to newly emerging infectious diseases Head Jeffrey Ulmer
11:30 ~ 12:10 Broadly Protective Influenza Vaccines: Protection Against Mismatched Strains Director Ted Ross
12:10 ~ 12:50 DNA Immunization for Vaccine and Monoclonal Antibody Development Professor Shan Lu
12:50 ~ 14:00 Lunch Time
14:00 ~ 16:20 Session 2. Glocal Vaccine Issues
14:00 ~ 14:40 Vaccines for the World : Role of DCVMN (Developing Countries Vaccine Manufacturers Network) Executive Director Suresh Jadhav
14:40 ~ 15:20 Pathway for BK-SE36 malaria vaccine development Professor Toshihiro Horii
15:20 ~ 15:50 RIGHT Fund, a new Platform for Korea to increase its contribution to Global Health CEO Younbeen Kim
15:50 ~ 16:20 Global collaboration for oral cholera vaccine development CEO Yeong Ok Baik
16:20 ~ 16:40 Coffee Break
16:40 ~ 18:00 Round table
Glocal Vaccine Market: Where are we?
18:00 ~ 18:10 Closing Ceremony
19:00 ~ 21:00 Welcome Dinner

* The program is subject to change.

2018 HIVF Speakers

Peter Kwong
Peter Kwong
Affiliation
Structural Bioinformatics Core Vaccine Research Center, NIAID
Title
Chief
Jeffrey Ulmer
Jeffrey Ulmer
Affiliation
Preclinical R&D US, GSK Vaccines
Title
Head
Ted Ross
Ted Ross
Affiliation
Center for Vaccines and Immunology, University of Georgia
Title
Director
Shan Lu
Shan Lu
Affiliation
University of Massachusetts Medical School
Title
Professor
Suresh Jadhav
Suresh Jadhav
Affiliation
Serum Institute of India Ltd.
Title
Executive Director
Toshihiro Horii
Toshihiro Horii
Affiliation
Osaka University
Title
Professor
Yoon-bin Kim
Younbeen Kim
Affiliation
RIGHT Fund
Title
CEO
Yeong-Ok Baik
Yeong Ok Baik
Affiliation
EuBiologics
Title
CEO